TCT-560 Paclitaxel-Eluting Balloon versus conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery. The ISAR-PEBIS randomized trial

TCT-560 Paclitaxel-Eluting Balloon versus conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery. The ISAR-PEBIS randomized trial

Background Paclitaxel-eluting balloon (PEB) angioplasty has superior efficacy as compared to conventional balloon angioplasty (BA) for de novo lesions of superficial femoral artery (SFA). Studies investigating the angiographic and clinical performance of PEB versus BA for in-stent restenosis (ISR) o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2017-10, Vol.70 (18), p.B232-B232
Hauptverfasser: Wittmann, Theresa, Cassese, Salvatore, Groha, Philipp, Steppich, Birgit, Voll, Felix, Hadamitzky, Martin, Ibrahim, Tareq, Kufner, Sebastian, Dewitz, Karl, Kasel, Markus, Laugwitz, Karl-Ludwig, Schunkert, Heribert, Kastrati, Adnan, Fusaro, Massimiliano, Ott, Ilka
Format: Artikel
Sprache:eng
Schlagworte:
Angioplasty
Balloon treatment
Cardiology
Femoral artery
Femur
Implants
Medical imaging
Paclitaxel
Restenosis
Stents
Studies
Surgical implants
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Paclitaxel-eluting balloon (PEB) angioplasty has superior efficacy as compared to conventional balloon angioplasty (BA) for de novo lesions of superficial femoral artery (SFA). Studies investigating the angiographic and clinical performance of PEB versus BA for in-stent restenosis (ISR) of SFA are limited.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2017.09.738